Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
85
NCT00729872
A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jul 31, 2008
Completion: Sep 30, 2009
NCT00938080
Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck
Phase: Phase 1
Start: Sep 30, 2009
Completion: Sep 30, 2012